Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BASAL GANGLIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | BASAL GANGLIA |
| Key Genes/Proteins | ACHE, AMYLOID, ATP13A2 |
| Related Diseases | ASTROGLIOSIS, CANCER |
graph TD
BASAL_GANGLIA["BASAL GANGLIA"]
BASAL_GANGLIA -->|"expressed in"| HUNTINGTON["HUNTINGTON"]
BASAL_GANGLIA -->|"expressed in"| HUNTINGTON_S["HUNTINGTON'S"]
BASAL_GANGLIA -->|"causes"| CANCER["CANCER"]
BASAL_GANGLIA -->|"impairs"| PARKIN["PARKIN"]
BASAL_GANGLIA -->|"impairs"| PARKINSON["PARKINSON"]
BASAL_GANGLIA -->|"impairs"| PARKINSON_S["PARKINSON'S"]
BASAL_GANGLIA -->|"impairs"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
BASAL_GANGLIA -->|"impairs"| SYNAPTIC_TRANSMISSION["SYNAPTIC TRANSMISSION"]
zona_incerta["zona incerta"] -->|"interacts"| BASAL_GANGLIA
ACHE["ACHE"] -->|"causes"| BASAL_GANGLIA
OCLN["OCLN"] -->|"expressed in"| BASAL_GANGLIA
GENES["GENES"] -->|"expressed in"| BASAL_GANGLIA
XPR1["XPR1"] -->|"expressed in"| BASAL_GANGLIA
SLC20A2["SLC20A2"] -->|"expressed in"| BASAL_GANGLIA
PDGFRB["PDGFRB"] -->|"expressed in"| BASAL_GANGLIA
PDGFB["PDGFB"] -->|"expressed in"| BASAL_GANGLIA| Target | Relation | Type | Str |
|---|---|---|---|
| FRONTOTEMPORAL DEMENTIA | causes | disease | 0.70 |
| HUNTINGTON'S | expressed_in | disease | 0.65 |
| HUNTINGTON | expressed_in | disease | 0.65 |
| WHITE MATTER | activates | brain_region | 0.65 |
| SYNAPTIC TRANSMISSION | associated_with | biological_process | 0.60 |
| PARKIN | associated_with | gene | 0.60 |
| PARKINSON | associated_with | disease | 0.60 |
| PARKINSON'S DISEASE | associated_with | disease | 0.60 |
| CANCER | causes | disease | 0.60 |
| PARKINSON'S | impairs | disease | 0.60 |
| WHITE MATTER | regulates | brain_region | 0.50 |
| DRD2 | associated_with | gene | 0.50 |
| SNCA | associated_with | gene | 0.50 |
| NEURON | associated_with | cell_type | 0.50 |
| STROKE | associated_with | disease | 0.50 |
| DOPAMINE | associated_with | phenotype | 0.50 |
| DEMENTIA | associated_with | disease | 0.50 |
| SEEDING | co_discussed | entity | 0.50 |
| THALAMUS | co_discussed | entity | 0.50 |
| MULTIPLE SCLEROSIS | co_discussed | entity | 0.50 |
| HYPOTHALAMUS | co_discussed | entity | 0.50 |
| CEREBELLUM | co_discussed | entity | 0.50 |
| TAU | co_discussed | entity | 0.50 |
| PYRAMIDAL | co_discussed | entity | 0.50 |
| PREFRONTAL | co_discussed | entity | 0.50 |
| STRIATUM | co_discussed | entity | 0.50 |
| PSP | co_discussed | entity | 0.50 |
| PARKINSON | co_discussed | entity | 0.50 |
| HIPPOCAMPUS | co_discussed | entity | 0.50 |
| CYTOKINE | co_discussed | entity | 0.50 |
| EPILEPSY | co_discussed | entity | 0.50 |
| PARKINSON'S | co_discussed | entity | 0.50 |
| CORTEX | co_discussed | entity | 0.50 |
| GPX4 | co_discussed | entity | 0.50 |
| CBD | co_discussed | entity | 0.50 |
| NEURON | co_discussed | entity | 0.50 |
| GLUTAMATE | co_discussed | entity | 0.50 |
| GLUTAMATERGIC | co_discussed | entity | 0.50 |
| MYELINATION | co_discussed | entity | 0.50 |
| NEURODEGENERATION | co_discussed | entity | 0.50 |
| DOPAMINERGIC | co_discussed | entity | 0.50 |
| SUBSTANTIA NIGRA | co_discussed | entity | 0.50 |
| GABA | co_discussed | entity | 0.50 |
| GABAergic | co_discussed | entity | 0.50 |
| SYNAPTIC PLASTICITY | co_discussed | entity | 0.50 |
| NEURONS | co_discussed | entity | 0.50 |
| AMYLOID | associated_with | protein | 0.45 |
| NRF2 | associated_with | gene | 0.45 |
| ATP13A2 | associated_with | gene | 0.45 |
| TH | associated_with | gene | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Primary Familial Brain Calcification | associated_with | disease | 0.95 |
| manganese | associated_with | process | 0.70 |
| zona incerta | interacts_with | brain_region | 0.70 |
| Parkinson's disease | affects | disease | 0.70 |
| neurodegeneration | affects | disease | 0.70 |
| SUBSTANTIA NIGRA | causes | brain_region | 0.65 |
| PARKINSON'S DISEASE | degrades | disease | 0.65 |
| neuroinflammation | affects | disease | 0.60 |
| epilepsy | affects | disease | 0.60 |
| GJA1 | expressed_in | gene | 0.60 |
| ACHE | causes | gene | 0.60 |
| Huntington's disease | affects | disease | 0.60 |
| PDGFRB | expressed_in | gene | 0.55 |
| OCLN | expressed_in | gene | 0.55 |
| PDGFB | expressed_in | gene | 0.55 |
| NLRP3 | expressed_in | gene | 0.55 |
| GENES | expressed_in | gene | 0.55 |
| C1Q | expressed_in | gene | 0.55 |
| HUNTINGTIN | expressed_in | gene | 0.55 |
| Addiction | associated_with | disease | 0.55 |
| XPR1 | expressed_in | gene | 0.55 |
| SLC20A2 | expressed_in | gene | 0.55 |
| EPILEPSY | expressed_in | gene | 0.55 |
| MITOCHONDRIAL DYSFUNCTION | expressed_in | gene | 0.55 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.55 |
| PARKINSON | expressed_in | gene | 0.55 |
| NEUROINFLAMMATION | expressed_in | gene | 0.55 |
| IFN | expressed_in | gene | 0.55 |
| IFN-Γ | expressed_in | gene | 0.55 |
| COMPLEMENT | expressed_in | gene | 0.55 |
| HUNTINGTON'S DISEASE | expressed_in | gene | 0.55 |
| HUNTINGTON | expressed_in | gene | 0.55 |
| FLT1 | expressed_in | gene | 0.55 |
| MICROGLIA | expressed_in | gene | 0.55 |
| IL1B | expressed_in | gene | 0.55 |
| PVALB | expressed_in | gene | 0.55 |
| TAU | expressed_in | gene | 0.55 |
| SYNAPSE | expressed_in | gene | 0.55 |
| STAT1 | expressed_in | gene | 0.55 |
| AND | expressed_in | gene | 0.55 |
| INFLAMMATION | expressed_in | gene | 0.55 |
| DEPRESSION | expressed_in | gene | 0.55 |
| IL-6 | expressed_in | gene | 0.55 |
| CANCER | expressed_in | gene | 0.55 |
| LRRK2 | expressed_in | gene | 0.55 |
| GABA | expressed_in | gene | 0.55 |
| Schizophrenia | associated_with | disease | 0.55 |
| SLC16A1 | expressed_in | gene | 0.55 |
| ALZHEIMER | expressed_in | gene | 0.55 |
| ASTROCYTES | expressed_in | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning BASAL GANGLIA in their description or question text
No additional research found